Burning Rock Biotech (BNR) Asset Utilization Ratio (2020 - 2026)

Burning Rock Biotech (BNR) has reported Asset Utilization Ratio for 7 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 5.36% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 0.63 (up 5.36% YoY), while the FY2025 annual figure was 0.65, up 22.53% from the prior year.
• Asset Utilization Ratio came in at 0.63 for Q1 2026 at Burning Rock Biotech, down from 0.66 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.66 in Q4 2025, with the low at 0.24 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.48, with a median of 0.51 recorded in 2024.
• Across the five-year window, Asset Utilization Ratio surged 67.07% in 2022 and advanced 5.36% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.36 in 2022, then surged by 38.93% to 0.5 in 2023, then rose by 9.63% to 0.54 in 2024, then climbed by 21.1% to 0.66 in 2025, then dropped by 3.61% to 0.63 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.63, 0.66, and 0.65 for Q1 2026, Q4 2025, and Q3 2025 respectively.